RecurX Bio

Baltimore, United States Founded: 2020 • Age: 6 yrs
Delivers comprehensive preclinical services for oncology drug development.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About RecurX Bio

RecurX Bio is a company based in Baltimore (United States) founded in 2020. It operates as a B2B. RecurX Bio operates in a competitive market with competitors including Redbud Medicine, OncoTheis, AlphaVax, Lukas Biomedical and DXOCRO, among others.

  • Headquarter Baltimore, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of RecurX Bio

Premium access

Detailed funding history for RecurX Bio

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by RecurX Bio

Investments
Premium access

Investment portfolio details for RecurX Bio

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - RecurX Bio

Premium access

Detailed financials for RecurX Bio

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Recurx Bio Comparisons

RecurX Bio Primary company
Description
Delivers comprehensive preclinical services for oncology dru...
Location
Baltimore, United States
Founded Year
2020
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for RecurX Bio

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of RecurX Bio

RecurX Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Redbud Medicine, OncoTheis, AlphaVax, Lukas Biomedical and DXOCRO, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Offers comprehensive services in regulatory affairs, R&D, data management, and statistical analysis for healthcare.
Locked Locked Locked
Provides 3D tissue testing services for in-vitro lung cancer drug testing.
Locked Locked Locked
Vaccines for infectious diseases and cancer immunotherapy are developed.
Locked Locked Locked
A biotechnology company developing autologous immune cell therapies to treat various types of cancer.
Locked Locked Locked
Provides in vitro diagnostic services for oncology research and development.
Locked Locked Locked
Offers tumoroid-based platforms for cancer drug screening and personalized medicine services.
Premium access

Detailed competitors of RecurX Bio

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Recurx Bio

Premium access

Complete news archive for RecurX Bio

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about RecurX Bio

RecurX Bio was founded in 2020.

RecurX Bio is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.

RecurX Bio, founded in 2020 in Baltimore, United States, focuses on providing healthcare solutions, advancing biotech innovations, drug development, and preclinical services. Delivers comprehensive preclinical services for oncology drug development. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

RecurX Bio's top competitors include Ontogen, AlphaVax and Cancer Research For Oza Rks.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available